Artificial Intelligence in the Operating Room

While the challenges in the healthcare industry are constantly increasing, hospitals adopting new technologies have helped to alleviate some of those struggles in the operating room. Discussing this topic is Dennis Kogan, co-founder, and CEO of Caresyntax, and Eric King, investment director at Intel Capital with host Alex Flores, Director of Global Health Solutions at Intel’s Network and Edge Group.

“It becomes a delicate system that combines facility-specific issues,” Kogan says. “Post-pandemic, there were factors like staffing where experienced nurses are leaving for various reasons and they are being replaced with, for example, younger professionals or traveling nurses which come into the system that is often quite tailored to individual setups of a facility or physician.”

Clearly, this change in operations has caused additional stress on staff and returning to pre-pandemic efficiency is a challenge.

King agreed, saying while the surgeon is the lead on the surgery, there are a lot of other members in the room who need to be properly trained. With staffing shortages as well as  nurses traveling in and out of the operating room, getting a team to work together efficiently with quality outcomes isn’t as simple as it was previously. To fill this gap, Caresyntax’s platforms can help improve team dynamics during a surgical procedure for the most successful staffing outcome.

The introduction of newer technology is supporting surgeons in real-time and using computer vision-based aides that do turn-by-turn type navigation of the operation. These technologies can determine anatomical structures and even warn physicians of the proximity of certain arteries.

Because of technology, experts can even remotely “step” into the operating room and provide guidance or feedback as surgeons are moving forward on complex surgeries.

“There are good artificial intelligent stratification mechanisms for being able to support more objectively the decision-making process for physicians or case managers at difficult stages,” Kogan says.

Caresyntax and Intel are looking to the future of innovation in medicine where the industry  “wraps the edge, the cloud, the analytics, the AI and automation, there is ample room for precision medicine surgery,” Kogan explains. “There are so many notes where take into account the data and the profile and create algorithms and applications that can help nudge the process in the optimal way in the decision tree you are creating personalized medicine in surgery, and that’s the big vision.”

To learn more, connect with Alex Flores, Dennis Kogan and Eric King on LinkedIn or visit Caresyntax.

Subscribe to this channel on Apple PodcastsSpotify, and Google Podcasts to hear more from the Intel Network & Edge Solutions Group.

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More